Abizer Gaslightwala
Fortune : 5 971 $ au 31/05/2025
Fortune : 5 971 $ au 31/05/2025
Abizer Gaslightwala currently holds the positions of President, Chief Executive Officer & Director at Akari Therapeutics Plc starting in 2025, and Senior Vice President at Jazz Pharmaceuticals Plc since 2020.
The education history includes graduate studies at Massachusetts Institute of Technology, undergraduate studies at Cornell University, and an MBA from MIT Sloan School of Management.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AKARI THERAPEUTICS PLC 1,12 % | 31/12/2025 | 597 148 000 ( 1,12 % ) | 5 971 $ | 31/05/2025 |
| Sociétés | Poste | Début |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Directeur Général | 21/04/2025 |
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/10/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akari Therapeutics Plc
Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national